首页 > 最新文献

Annals of vascular surgery最新文献

英文 中文
The Incidence and Significance of Iliac Vein Stenosis in Patients with Deep Vein Thrombosis 深静脉血栓患者髂静脉狭窄的发生率及意义。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.016
Sahar Ali , Shin Mei Chan , Anand Brahmandam , Yunshan Xu , Yanhong Deng , Ahmed Elbadawy , Alfred Lee , Cassius Iyad Ochoa Chaar

Background

The role of iliac vein stenosis (IVS) in the development of deep vein thrombosis (DVT) is poorly understood. This study determines the incidence of IVS in patients diagnosed with DVT and assesses its impact on presentation and outcomes. Our hypothesis is that the presence of IVS increases the risk of long-term ipsilateral DVT recurrence.

Methods

A retrospective study of the electronic medical records of consecutive adult patients treated for lower extremity DVT was performed. Only patients with cross-sectional imaging (computed tomography or magnetic resonance with intravenous contrast) were included. Patient and DVT characteristics were recorded. Cross-sectional imaging was reviewed for the presence or absence of ipsilateral IVS (≥50%). Patients were divided into 2 groups based on the presence or absence of IVS to compare characteristics and outcomes. Subgroup analyses on patients with provoked DVT, cancer-related DVT, and unprovoked DVT were performed.

Results

There were 548 patients with DVT and 32% had evidence of ipsilateral IVS on cross-sectional imaging. There were no significant differences in baseline characteristics or treatment methods between the 2 groups. There was a trend toward patients with IVS having less incidence of pulmonary embolism on presentation (22.9% vs. 29.7%, P = 0.1) but that difference did not reach statistical significance in the overall comparison. Subgroup analysis in patients with cancer-related DVT (n = 227) showed that patients with IVS were significantly more likely to develop ipsilateral recurrent DVT compared to patients with no IVS (12.9% vs. 4.5%, P = 0.045). Patients with unprovoked DVT with IVS had significantly lower pulmonary embolism on presentation than patients with unprovoked DVT without IVS (24.2% vs. 39.8%, P < 0.03).

Conclusions

Ipsilateral ≥50% IVS is present in approximately a third of patients presenting with DVT. The presence of IVS seems to play a differential role in ipsilateral DVT recurrence and prevention of pulmonary embolization in different groups of patients presenting with DVT.
目的:髂静脉狭窄(IVS)在DVT发展中的作用尚不清楚。本研究确定了诊断为DVT的患者中IVS的发生率,并评估其对表现和预后的影响。我们的假设是IVS的存在增加了同侧DVT长期复发的风险。方法:回顾性分析连续治疗下肢深静脉血栓的成人患者的电子病历。仅包括横断成像(CT或MR加静脉造影剂)的患者。记录患者及深静脉血栓特征。横断成像检查同侧IVS是否存在(≥50%)。根据是否存在IVS将患者分为两组,比较特征和结果。对诱发性深静脉血栓患者、癌症相关深静脉血栓患者和非诱发性深静脉血栓患者进行亚组分析。结果:548例深静脉血栓患者,32%的患者有同侧静脉血栓。两组患者的基线特征和治疗方法无显著差异。IVS患者首发时PE发生率有降低的趋势(22.9% vs 29.7%, P=0.1),但总体比较差异无统计学意义。癌症相关DVT患者的亚组分析(n=227)显示,与没有IVS的患者相比,IVS患者更容易发生同侧复发性DVT (12.9% vs 4.5%, P=0.045)。非诱发性DVT合并IVS的患者与无IVS的非诱发性DVT患者相比,出现时PE显著降低(24.2% vs 39.8%)。结论:大约三分之一的DVT患者出现同侧IVS≥50%。IVS的存在似乎在不同组DVT患者的同侧DVT复发和肺栓塞预防中起着不同的作用。
{"title":"The Incidence and Significance of Iliac Vein Stenosis in Patients with Deep Vein Thrombosis","authors":"Sahar Ali ,&nbsp;Shin Mei Chan ,&nbsp;Anand Brahmandam ,&nbsp;Yunshan Xu ,&nbsp;Yanhong Deng ,&nbsp;Ahmed Elbadawy ,&nbsp;Alfred Lee ,&nbsp;Cassius Iyad Ochoa Chaar","doi":"10.1016/j.avsg.2024.11.016","DOIUrl":"10.1016/j.avsg.2024.11.016","url":null,"abstract":"<div><h3>Background</h3><div>The role of iliac vein stenosis (IVS) in the development of deep vein thrombosis (DVT) is poorly understood. This study determines the incidence of IVS in patients diagnosed with DVT and assesses its impact on presentation and outcomes. Our hypothesis is that the presence of IVS increases the risk of long-term ipsilateral DVT recurrence.</div></div><div><h3>Methods</h3><div>A retrospective study of the electronic medical records of consecutive adult patients treated for lower extremity DVT was performed. Only patients with cross-sectional imaging (computed tomography or magnetic resonance with intravenous contrast) were included. Patient and DVT characteristics were recorded. Cross-sectional imaging was reviewed for the presence or absence of ipsilateral IVS (≥50%). Patients were divided into 2 groups based on the presence or absence of IVS to compare characteristics and outcomes. Subgroup analyses on patients with provoked DVT, cancer-related DVT, and unprovoked DVT were performed.</div></div><div><h3>Results</h3><div>There were 548 patients with DVT and 32% had evidence of ipsilateral IVS on cross-sectional imaging. There were no significant differences in baseline characteristics or treatment methods between the 2 groups. There was a trend toward patients with IVS having less incidence of pulmonary embolism on presentation (22.9% vs. 29.7%, <em>P</em> = 0.1) but that difference did not reach statistical significance in the overall comparison. Subgroup analysis in patients with cancer-related DVT (<em>n</em> = 227) showed that patients with IVS were significantly more likely to develop ipsilateral recurrent DVT compared to patients with no IVS (12.9% vs. 4.5%, <em>P</em> = 0.045). Patients with unprovoked DVT with IVS had significantly lower pulmonary embolism on presentation than patients with unprovoked DVT without IVS (24.2% vs. 39.8%, <em>P</em> &lt; 0.03).</div></div><div><h3>Conclusions</h3><div>Ipsilateral ≥50% IVS is present in approximately a third of patients presenting with DVT. The presence of IVS seems to play a differential role in ipsilateral DVT recurrence and prevention of pulmonary embolization in different groups of patients presenting with DVT.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 310-318"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Iliofemoral Calcium Score and Major Vascular Complications within the First Year after Lower Limb Endovascular Revascularization 髂股骨钙化评分与下肢血管内血运重建术后第一年内主要血管并发症的关系。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.009
Raul Devia-Rodriguez , Maikel Derksen , Mostafa El Moumni , Kristian de Groot , Issi R. Vedder , Clark J. Zeebregts , Reinoud P.H. Bokkers , Robert A. Pol , Jean-Paul P.M. de Vries , Richte C.L. Schuurmann

Background

The accumulation of calcium load in peripheral lower extremity arteries has been associated with increased severity of peripheral artery disease (PAD) and mortality. While calcium scores are commonly calculated from non-contrast computed tomography (CT) scans, patients with PAD often undergo contrast-enhanced CT scans. This study aims to explore the association between a length-adjusted calcium score (LACS) of the iliofemoral arteries, determined through pre-intervention contrast-enhanced CT, and major adverse events in patients with chronic limb-threatening ischemia (CLTI).

Methods

A cohort of CLTI patients subjected to endovascular revascularization between 2005 and 2017 at a tertiary referral center were categorized into 2 groups. The complication group experienced one of the composite outcomes (reintervention, above-the-ankle amputation, and/or all-cause mortality within 1 year of the primary endovascular procedure), while control patients did not encounter this composite endpoint. Patients from the complication group were matched one-to-one with controls based on sex and Fontaine classification. LACS was calculated (Ca volume[mm3]/length[cm]) at 3 arterial segments; 1. the common iliac artery (CIA), 2. the external iliac artery and common femoral artery (EIA + CFA), and 3. the superficial femoral artery plus the popliteal artery (SFA + PA). Binary logistic regression analysis was conducted to investigate the association between LACS in the different arterial segments and the occurrence of the composite binary outcome (complication and control) and LACS of the different segments, adjusting influences of age, sex, BMI >25, Fontaine classification, diabetes mellitus type 1 & 2, chronic kidney disease stage, and hemodialysis treatment.

Results

Sixty-four CLTI patients were included in this study (complication group [n = 32], and control group [n = 32]). A significant difference (higher LACS was found for the complication group in the CIA, the SFA + PA, as well as the total trajectory. CLTI patients with high LACS in the SFA + PA or the total trajectory were more likely to suffer adverse events (SFA + PA: OR: 1.010, 95% CI: 1.000–1.020, P = 0.04; Total LACS: OR: 1.008, 95% CI: 1.000–1.017, P = 0.05).

Conclusions

Patients with a high calcium load in the ilio-femoral arteries are at increased risk of major adverse events during 1 year after endovascular revascularization. The calcium score, derived from contrast-enhanced CT scans, holds potential utility in decision making for CLTI patients.
背景:下肢外周动脉中钙负荷的累积与外周动脉疾病(PAD)的严重程度和死亡率的增加有关。钙负荷通常通过非对比度计算机断层扫描(CT)来计算,而 PAD 患者通常要接受对比度增强 CT 扫描。本研究旨在探讨通过干预前造影剂增强 CT 确定的髂股动脉长度调整钙评分(LACS)与慢性肢体缺血(CLTI)患者主要不良事件之间的关系:2005年至2017年间在一家三级转诊中心接受血管内再通术的CLTI患者被分为两组。并发症组患者在主要血管内手术后一年内出现复合终点(再次介入、踝关节以上截肢和/或全因死亡)之一,而对照组患者未出现该复合终点。并发症组患者根据性别和方丹分类与对照组患者进行一对一配对。计算三个动脉段的 LACS(Ca 体积[mm3]/长度[cm]):1.髂总动脉(CIA);2.髂外动脉和股总动脉(EIA+CFA);3.股浅动脉加腘动脉(SFA+PA)。在调整了年龄、性别、BMI >25、方丹分级、1型和2型糖尿病、慢性肾脏病分期和血液透析治疗的影响因素后,进行了二元逻辑回归分析,以研究不同动脉节段的LACS与二元复合结果(并发症和控制)的发生以及不同节段的LACS之间的关系:本研究共纳入 64 例 CLTI 患者(并发症组 32 例,对照组 32 例)。发现并发症组在 CIA、SFA+PA 和总轨迹上存在明显差异(LACS 较高)。SFA+PA或总轨迹中LACS较高的CLTI患者更有可能发生不良事件(SFA+PA:OR:1.010,95% CI:1.000-1.020,P=0.04;Total LACS:OR:1.008,95% CI:1.000-1.017,P=0.05):结论:髂股动脉钙负荷较高的患者在血管内血运重建术后一年内发生重大不良事件的风险较高。从对比增强CT扫描中得出的钙化评分在CLTI患者的决策中具有潜在的实用性。
{"title":"Association of Iliofemoral Calcium Score and Major Vascular Complications within the First Year after Lower Limb Endovascular Revascularization","authors":"Raul Devia-Rodriguez ,&nbsp;Maikel Derksen ,&nbsp;Mostafa El Moumni ,&nbsp;Kristian de Groot ,&nbsp;Issi R. Vedder ,&nbsp;Clark J. Zeebregts ,&nbsp;Reinoud P.H. Bokkers ,&nbsp;Robert A. Pol ,&nbsp;Jean-Paul P.M. de Vries ,&nbsp;Richte C.L. Schuurmann","doi":"10.1016/j.avsg.2024.11.009","DOIUrl":"10.1016/j.avsg.2024.11.009","url":null,"abstract":"<div><h3>Background</h3><div>The accumulation of calcium load in peripheral lower extremity arteries has been associated with increased severity of peripheral artery disease (PAD) and mortality. While calcium scores are commonly calculated from non-contrast computed tomography (CT) scans, patients with PAD often undergo contrast-enhanced CT scans. This study aims to explore the association between a length-adjusted calcium score (LACS) of the iliofemoral arteries, determined through pre-intervention contrast-enhanced CT, and major adverse events in patients with chronic limb-threatening ischemia (CLTI).</div></div><div><h3>Methods</h3><div>A cohort of CLTI patients subjected to endovascular revascularization between 2005 and 2017 at a tertiary referral center were categorized into 2 groups. The complication group experienced one of the composite outcomes (reintervention, above-the-ankle amputation, and/or all-cause mortality within 1 year of the primary endovascular procedure), while control patients did not encounter this composite endpoint. Patients from the complication group were matched one-to-one with controls based on sex and Fontaine classification. LACS was calculated (Ca volume[mm<sup>3</sup>]/length[cm]) at 3 arterial segments; 1. the common iliac artery (CIA), 2. the external iliac artery and common femoral artery (EIA + CFA), and 3. the superficial femoral artery plus the popliteal artery (SFA + PA). Binary logistic regression analysis was conducted to investigate the association between LACS in the different arterial segments and the occurrence of the composite binary outcome (complication and control) and LACS of the different segments, adjusting influences of age, sex, BMI &gt;25, Fontaine classification, diabetes mellitus type 1 &amp; 2, chronic kidney disease stage, and hemodialysis treatment.</div></div><div><h3>Results</h3><div>Sixty-four CLTI patients were included in this study (complication group [<em>n</em> = 32], and control group [<em>n</em> = 32]). A significant difference (higher LACS was found for the complication group in the CIA, the SFA + PA, as well as the total trajectory. CLTI patients with high LACS in the SFA + PA or the total trajectory were more likely to suffer adverse events (SFA + PA: OR: 1.010, 95% CI: 1.000–1.020, <em>P</em> = 0.04; Total LACS: OR: 1.008, 95% CI: 1.000–1.017, <em>P</em> = 0.05).</div></div><div><h3>Conclusions</h3><div>Patients with a high calcium load in the ilio-femoral arteries are at increased risk of major adverse events during 1 year after endovascular revascularization. The calcium score, derived from contrast-enhanced CT scans, holds potential utility in decision making for CLTI patients.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 290-298"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Negative Pressure Wound Therapy on Groin Surgical Site Infection After Lower Extremity Bypass for Chronic Limb-Threatening Ischemia 负压伤口疗法对慢性肢体缺血下肢搭桥术后腹股沟手术部位感染的疗效。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.020
Young Kim, Christina L. Cui, Hana S. Shafique, E. Hope Weissler, Adam P. Johnson, Dawn M. Coleman, Kevin W. Southerland

Background

Surgical site infections (SSIs) are a common cause of patient morbidity, hospital readmission, and reoperation after lower extremity bypass (LEBs) surgery for chronic limb-threatening ischemia (CLTI). Recent studies on the use of incisional negative pressure wound therapy (NPWT) in LEB surgery have reported conflicting results. In this single-center study, we examined our experience on the impact of NPWT on groin SSI rates after LEB surgery.

Methods

We retrospectively queried electronic medical records for all LEB operations performed for CLTI. Multivariate logistic regression analysis was used to identify risk factors associated with postoperative SSI. Using these risk factors, subset analysis was performed to determine whether NPWT was associated with reduced SSI in high-risk patients.

Results

From 2018 to 2022, a total of 367 patients underwent LEB surgery for CLTI. Mean patient age was 66 years. Postoperative groin SSI was diagnosed in 22.9% (n = 84) of patients. Patients suffering SSI were more frequently morbidly obese (6.0% vs 1.8%, P = 0.03) and had higher rates of chronic obstructive pulmonary disease (35.7% vs 23.3%, P = 0.02). Other comorbidities and demographic data were similar between groups. NPWT was utilized in 19.6% (n = 72) of patients, with no baseline differences between SSI and no SSI cohorts (15.5% vs 20.9%, P = 0.28). On multivariate analysis, female sex (odds ratio [OR] 1.88, 95% confidence interval [CI] 1.06–3.35, P = 0.03), white race (OR 2.17, 95% CI 1.23–3.82, P = 0.007), morbid obesity (OR 3.67, 95% CI 0.93–14.4, P = 0.05), and active smoking (OR 4.07, 95% CI 1.20–13.8, P = 0.02) were independently associated with postoperative SSI. Subset analysis among patients at increased risk of SSI did not reveal any differences in wound infection with NPWT usage.

Conclusions

In our experience, NPWT does not appear to be more effective than standard dressings in preventing groin SSI after LEB surgery for CLTI, even among populations at heightened risk for wound infection.
背景:手术部位感染(SSI)是导致慢性肢体缺血(CLTI)下肢搭桥(LEB)手术后患者发病、再次入院和再次手术的常见原因。最近关于在 LEB 手术中使用切口负压伤口疗法(NPWT)的研究报告结果相互矛盾。在这项单中心研究中,我们探讨了 NPWT 对 LEB 手术后腹股沟 SSI 感染率的影响:我们回顾性地查询了所有因 CLTI 而进行的 LEB 手术的电子病历。采用多变量逻辑回归分析确定与术后 SSI 相关的风险因素。利用这些风险因素进行子集分析,以确定 NPWT 是否与减少高风险患者的 SSI 相关:从2018年到2022年,共有367名患者因CLTI接受了LEB手术。患者平均年龄为 66 岁。22.9%(n=84)的患者确诊为术后腹股沟 SSI。SSI 患者多为病态肥胖(6.0% 对 1.8%,P=0.03),慢性阻塞性肺病患者比例较高(35.7% 对 23.3%,P=0.02)。两组患者的其他合并症和人口统计学数据相似。19.6%(72 人)的患者使用了 NPWT,SSI 和无 SSI 组间无基线差异(15.5% vs 20.9%,P=0.28)。在多变量分析中,女性性别(比值比 [OR] 1.88,95% 置信区间 [CI] 1.06-3.35,p=0.03)、白种人(OR 2.17,95% CI 1.23-3.82,p=0.007)、病态肥胖(OR 3.67,95% CI 0.93-14.4,p=0.05)和主动吸烟(OR 4.07,95% CI 1.20-13.8,p=0.02)与术后 SSI 独立相关。对SSI风险较高的患者进行的子集分析并未发现使用NPWT对伤口感染有任何影响:根据我们的经验,在预防LEB手术治疗CLTI后腹股沟SSI方面,NPWT似乎并不比标准敷料更有效,即使在伤口感染风险较高的人群中也是如此。
{"title":"Effectiveness of Negative Pressure Wound Therapy on Groin Surgical Site Infection After Lower Extremity Bypass for Chronic Limb-Threatening Ischemia","authors":"Young Kim,&nbsp;Christina L. Cui,&nbsp;Hana S. Shafique,&nbsp;E. Hope Weissler,&nbsp;Adam P. Johnson,&nbsp;Dawn M. Coleman,&nbsp;Kevin W. Southerland","doi":"10.1016/j.avsg.2024.10.020","DOIUrl":"10.1016/j.avsg.2024.10.020","url":null,"abstract":"<div><h3>Background</h3><div>Surgical site infections (SSIs) are a common cause of patient morbidity, hospital readmission, and reoperation after lower extremity bypass (LEBs) surgery for chronic limb-threatening ischemia (CLTI). Recent studies on the use of incisional negative pressure wound therapy (NPWT) in LEB surgery have reported conflicting results. In this single-center study, we examined our experience on the impact of NPWT on groin SSI rates after LEB surgery.</div></div><div><h3>Methods</h3><div>We retrospectively queried electronic medical records for all LEB operations performed for CLTI. Multivariate logistic regression analysis was used to identify risk factors associated with postoperative SSI. Using these risk factors, subset analysis was performed to determine whether NPWT was associated with reduced SSI in high-risk patients.</div></div><div><h3>Results</h3><div>From 2018 to 2022, a total of 367 patients underwent LEB surgery for CLTI. Mean patient age was 66 years. Postoperative groin SSI was diagnosed in 22.9% (<em>n</em> = 84) of patients. Patients suffering SSI were more frequently morbidly obese (6.0% vs 1.8%, <em>P</em> = 0.03) and had higher rates of chronic obstructive pulmonary disease (35.7% vs 23.3%, <em>P</em> = 0.02). Other comorbidities and demographic data were similar between groups. NPWT was utilized in 19.6% (<em>n</em> = 72) of patients, with no baseline differences between SSI and no SSI cohorts (15.5% vs 20.9%, <em>P</em> = 0.28). On multivariate analysis, female sex (odds ratio [OR] 1.88, 95% confidence interval [CI] 1.06–3.35, <em>P</em> = 0.03), white race (OR 2.17, 95% CI 1.23–3.82, <em>P</em> = 0.007), morbid obesity (OR 3.67, 95% CI 0.93–14.4, <em>P</em> = 0.05), and active smoking (OR 4.07, 95% CI 1.20–13.8, <em>P</em> = 0.02) were independently associated with postoperative SSI. Subset analysis among patients at increased risk of SSI did not reveal any differences in wound infection with NPWT usage.</div></div><div><h3>Conclusions</h3><div>In our experience, NPWT does not appear to be more effective than standard dressings in preventing groin SSI after LEB surgery for CLTI, even among populations at heightened risk for wound infection.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 143-150"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Updated Review on Arterial Stiffness Measurement Techniques and Arterial Stiffness Alterations After Aortic Aneurysm Repair 动脉刚度测量技术和主动脉瘤修复后动脉刚度改变的最新综述。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.018
Michail Tsotsios , Athanasios Katsargyris , Konstantinos G. Moulakakis , Evangelos Oikonomou , Vasiliki Tsigkou , Natasha Hasemaki , Gerasimos Siasos , Chris Klonaris

Background

Studies over the last years have revealed the possible impact of endovascular repair of abdominal or thoracic aortic aneurysms on the arterial stiffness and secondary on the cardiac function and the central hemodynamics.

Methods

A literature search was conducted to collect data on current methods of arterial stiffness assessment and the induced changes in arterial stiffness after endovascular or open surgical repair of abdominal or thoracic aortic aneurysms.

Results

Seventeen studies were analyzed. In most of these studies, arterial stiffness, either assessed by pulse wave velocity or augmentation index, was found to be increased after aortic aneurysm repair. Factors that increase arterial stiffness seem to be endovascular repair of the aneurysm and the proximity of the stent graft to the heart. The clinical implications of increased arterial stiffness are left ventricular hypertrophy, coronary arteries malperfusion and potential end-organ damage.

Conclusions

Both endovascular and open aortic aneurysm repair can alter arterial stiffness, with endovascular repair having a greater effect. Future research is essential, particularly in exploring the impact of aortic aneurysm repair methods on vital organs and cardiac function. Extended follow-up studies are proposed to gain a better understanding of the long-term cardiovascular consequences of both endovascular and open surgical repair outcomes.
背景:近年来的研究揭示了腹、胸主动脉瘤血管内修复对动脉僵硬度的影响,以及对心功能和中央血流动力学的影响。方法:通过文献检索,收集目前动脉僵硬度评估方法及腹、胸主动脉瘤血管内或开放性手术修复后动脉僵硬度变化的相关资料。结果:分析了17项研究。在大多数研究中,通过脉搏波速度或增强指数评估的动脉僵硬度在主动脉瘤修复后均有所增加。增加动脉僵硬的因素似乎是动脉瘤的血管内修复和支架靠近心脏。动脉硬度增加的临床意义是左心室肥厚、冠状动脉灌注不良和潜在的终末器官损伤。结论:血管内修复和开放式动脉瘤修复均可改变动脉僵硬度,其中血管内修复效果更大。未来的研究是必要的,特别是探索主动脉瘤修复方法对重要器官和心脏功能的影响。为了更好地了解血管内和开放手术修复结果的长期心血管后果,建议进行延长的随访研究。
{"title":"An Updated Review on Arterial Stiffness Measurement Techniques and Arterial Stiffness Alterations After Aortic Aneurysm Repair","authors":"Michail Tsotsios ,&nbsp;Athanasios Katsargyris ,&nbsp;Konstantinos G. Moulakakis ,&nbsp;Evangelos Oikonomou ,&nbsp;Vasiliki Tsigkou ,&nbsp;Natasha Hasemaki ,&nbsp;Gerasimos Siasos ,&nbsp;Chris Klonaris","doi":"10.1016/j.avsg.2024.11.018","DOIUrl":"10.1016/j.avsg.2024.11.018","url":null,"abstract":"<div><h3>Background</h3><div>Studies over the last years have revealed the possible impact of endovascular repair of abdominal or thoracic aortic aneurysms on the arterial stiffness and secondary on the cardiac function and the central hemodynamics.</div></div><div><h3>Methods</h3><div>A literature search was conducted to collect data on current methods of arterial stiffness assessment and the induced changes in arterial stiffness after endovascular or open surgical repair of abdominal or thoracic aortic aneurysms.</div></div><div><h3>Results</h3><div>Seventeen studies were analyzed. In most of these studies, arterial stiffness, either assessed by pulse wave velocity or augmentation index, was found to be increased after aortic aneurysm repair. Factors that increase arterial stiffness seem to be endovascular repair of the aneurysm and the proximity of the stent graft to the heart. The clinical implications of increased arterial stiffness are left ventricular hypertrophy, coronary arteries malperfusion and potential end-organ damage.</div></div><div><h3>Conclusions</h3><div>Both endovascular and open aortic aneurysm repair can alter arterial stiffness, with endovascular repair having a greater effect. Future research is essential, particularly in exploring the impact of aortic aneurysm repair methods on vital organs and cardiac function. Extended follow-up studies are proposed to gain a better understanding of the long-term cardiovascular consequences of both endovascular and open surgical repair outcomes.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 299-309"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence to Enhance Future Clinical Trials in Vascular Surgery 人工智能将增强血管外科的临床试验。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.019
Sebastien Goffart, Andréa Chierici, Lisa Guzzi, Hervé Delingette, Ahmed Alouane, Fabien Lareyre, Juliette Raffort
{"title":"Artificial Intelligence to Enhance Future Clinical Trials in Vascular Surgery","authors":"Sebastien Goffart,&nbsp;Andréa Chierici,&nbsp;Lisa Guzzi,&nbsp;Hervé Delingette,&nbsp;Ahmed Alouane,&nbsp;Fabien Lareyre,&nbsp;Juliette Raffort","doi":"10.1016/j.avsg.2024.11.019","DOIUrl":"10.1016/j.avsg.2024.11.019","url":null,"abstract":"","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 331-335"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid Ultrasound Assessment Prior to Coronary Artery Bypass Grafting – An Irish Cardiac Surgery Center's Experience 冠状动脉旁路移植术前的颈动脉超声评估--爱尔兰心脏外科中心的经验。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.012
John David Kehoe , Amber Downes , Aoife Feeley , Sean Barrett , Carl Vaughan , Tara Ni Dhonnchu

Background

Carotid stenosis is a risk factor for cerebrovascular accident (CVA) following coronary artery bypass grafting (CABG). Guidelines recommend selective preoperative screening with Doppler ultrasound (US) but nonselective application is commonplace. Recent data has questioned the efficacy of perioperative carotid intervention, challenging the value of this practice. We thus aimed to analyze the utility of carotid US assessment prior to CABG in our institution.

Methods

This was a retrospective review of all patients over 18 that underwent a nonemergency CABG in a single Irish cardiac surgery center from January 2019 to December 2022.

Results

1161 subjects were included. 1084/1161 (93.36%) underwent US assessment. 41/1084 (3.8%) had ≥70% stenosis and 189/1084 (17.5%) had ≥50% stenosis. 32/1084 (2.95%) underwent confirmatory imaging and 7/1084 (0.64%) underwent carotid intervention. Postoperative CVA occurred in 18/1161 (1.55%) and ≥70% (P = 0.024) and ≥50%(P < 0.001) carotid stenosis were associated with same.
Chronic kidney disease (odds ratio [OR] = 1.66,P = 0.01), decreasing hemoglobin (OR = 1.13,P = 0.019), increasing age (OR = 1.03,P = 0.011) and being a current (OR = 3.21,P < 0.001) or ex-smoker (OR = 1.82,P = 0.004) were risk factors for ≥50% carotid stenosis on logistic regression. Multivessel coronary artery disease (CAD) was not associated with carotid stenosis (P = 0.563).
Of those that underwent carotid intervention, 0/7 (0%) suffered a CVA, but this protective effect failed to reach statistical significance for those with ≥70% (P = 1) or ≥50% (P = 1) carotid stenosis.

Conclusions

Carotid US screening altered the management of only a small proportion of CABG patients despite near universal application, challenging the effectiveness of this practice. Multivessel CAD was not associated with carotid stenosis despite European guidelines listing it as screening criteria. Predictive models must be developed using identified risk factors to enable targeted preoperative screening.
导言:颈动脉狭窄是冠状动脉旁路移植术(CABG)后发生脑血管意外的危险因素。指南建议术前使用多普勒超声进行选择性筛查,但非选择性筛查却很普遍。最近的数据对围手术期颈动脉介入治疗的疗效提出了质疑,对这一做法的价值提出了挑战。目的:分析本院在 CABG 术前进行颈动脉 US 评估的效用:这是一项回顾性研究,研究对象是2019年1月至2022年12月期间在爱尔兰一家心脏外科中心接受非急诊CABG手术的所有18岁以上患者:结果:共纳入1161名受试者。1084/1161(93.36%)人接受了US评估。41/1084(3.8%)例血管狭窄≥70%,189/1084(17.5%)例血管狭窄≥50%。32/1084(2.95%)人接受了确诊成像检查,7/1084(0.64%)人接受了颈动脉介入治疗。18/1161(1.55%)和≥70%(P=0.024)和≥50%(P结论:尽管颈动脉US筛查几乎得到了普遍应用,但它只改变了一小部分CABG患者的治疗,这对这一做法的有效性提出了挑战。多支冠状动脉疾病与颈动脉狭窄无关,尽管欧洲指南将其列为筛查标准。必须利用已确定的风险因素开发预测模型,以便进行有针对性的术前筛查。
{"title":"Carotid Ultrasound Assessment Prior to Coronary Artery Bypass Grafting – An Irish Cardiac Surgery Center's Experience","authors":"John David Kehoe ,&nbsp;Amber Downes ,&nbsp;Aoife Feeley ,&nbsp;Sean Barrett ,&nbsp;Carl Vaughan ,&nbsp;Tara Ni Dhonnchu","doi":"10.1016/j.avsg.2024.10.012","DOIUrl":"10.1016/j.avsg.2024.10.012","url":null,"abstract":"<div><h3>Background</h3><div>Carotid stenosis is a risk factor for cerebrovascular accident (CVA) following coronary artery bypass grafting (CABG). Guidelines recommend selective preoperative screening with Doppler ultrasound (US) but nonselective application is commonplace. Recent data has questioned the efficacy of perioperative carotid intervention, challenging the value of this practice. We thus aimed to analyze the utility of carotid US assessment prior to CABG in our institution.</div></div><div><h3>Methods</h3><div>This was a retrospective review of all patients over 18 that underwent a nonemergency CABG in a single Irish cardiac surgery center from January 2019 to December 2022.</div></div><div><h3>Results</h3><div>1161 subjects were included. 1084/1161 (93.36%) underwent US assessment. 41/1084 (3.8%) had ≥70% stenosis and 189/1084 (17.5%) had ≥50% stenosis. 32/1084 (2.95%) underwent confirmatory imaging and 7/1084 (0.64%) underwent carotid intervention. Postoperative CVA occurred in 18/1161 (1.55%) and ≥70% (<em>P</em> = 0.024) and ≥50%(<em>P</em> &lt; 0.001) carotid stenosis were associated with same.</div><div>Chronic kidney disease (odds ratio [OR] = 1.66,<em>P</em> = 0.01), decreasing hemoglobin (OR = 1.13,<em>P</em> = 0.019), increasing age (OR = 1.03,<em>P</em> = 0.011) and being a current (OR = 3.21,<em>P</em> &lt; 0.001) or ex-smoker (OR = 1.82,<em>P</em> = 0.004) were risk factors for ≥50% carotid stenosis on logistic regression. Multivessel coronary artery disease (CAD) was not associated with carotid stenosis (<em>P</em> = 0.563).</div><div>Of those that underwent carotid intervention, 0/7 (0%) suffered a CVA, but this protective effect failed to reach statistical significance for those with ≥70% (<em>P</em> = 1) or ≥50% (<em>P</em> = 1) carotid stenosis.</div></div><div><h3>Conclusions</h3><div>Carotid US screening altered the management of only a small proportion of CABG patients despite near universal application, challenging the effectiveness of this practice. Multivessel CAD was not associated with carotid stenosis despite European guidelines listing it as screening criteria. Predictive models must be developed using identified risk factors to enable targeted preoperative screening.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 176-186"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft 不要混淆!不同近端主动脉袖带与 AFX 内植物的长期疗效。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.024
Giulio Accarino , Aniello Enrico Puca , Antonia Rinaldi , Giovanni Fornino , Giancarlo Accarino , Davide Turchino , Raffaele Serra , Sergio Furgiuele , Carmine Vecchione , Umberto Marcello Bracale

Background

The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff. This study aims to evaluate the long-term outcomes of patients treated with an all-Endologix implant versus a combination of Endologix and Medtronic devices.

Methods

This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (n = 86) or Medtronic (n = 48) between November 2011 and November 2022. Patients were divided into 2 groups based on the type of aortic cuff used. The primary outcome was the occurrence of type 3A endoleaks at the longest available follow-up. Secondary outcomes included any endoleak, reintervention rates, all-cause mortality, and aneurysm-related death.

Results

The median follow-up was 41 months, and type 3A endoleaks occurred after a mean 34.8 months in 6 patients (4.5%), which is significantly more frequent in the mixed-device group (12.8%) (P < 0.001). Type 3A endoleak occurred regardless of overlap and developed over time. Endoleaks of any type were reported in 17 patients. Reinterventions were needed in 12 patients. The use of an Endurant cuff was associated with a significantly increased risk of type 3A endoleaks (hazard ratio [HR] 16.5; 95% [CI] 1.9–143; P = 0.011) and reinterventions (HR 9.67; 95% CI 1.9–49.6; P = 0.006).

Conclusions

Combining endografts from different manufacturers, especially those with differing materials and sealing mechanisms, may compromise the long-term integrity of certain EVAR repairs. Clinicians should exercise caution when considering mixed-device configurations and ensure rigorous follow-up for patients with such implants.
背景:AFX 一体式内植物移植因其独特的设计而在治疗主动脉分叉狭窄的腹主动脉瘤(AAA)方面具有优势,其分流器位于原生主动脉分叉处。不过,其有限的长度选择可能会限制近端颈部的完全利用。根据设备使用说明,植入时应使用主动脉袖带。本研究旨在评估采用全 Endologix 装置与 Endologix 和美敦力装置组合治疗患者的长期疗效:这项回顾性单中心研究纳入了 2011 年 11 月至 2022 年 11 月间连续接受血管内动脉瘤修补术(EVAR)的 134 例 AAA 患者,他们都使用了 AFX 一体式内植物和 Endologix(86 例)或 Medtronic(48 例)的肾上主动脉袖带。根据使用的主动脉袖带类型将患者分为两组。主要结果是在最长的随访时间内发生 3A 型内漏。次要结果包括任何内漏、再介入率、全因死亡率和动脉瘤相关死亡:中位随访时间为41个月,6名患者(4.5%)在平均34.8个月后发生3A型内膜渗漏,混合装置组的发生率明显更高(12.8%)(p结论:将不同制造商生产的内植物组合在一起,尤其是材料和密封机制不同的内植物,可能会损害某些 EVAR 修复术的长期完整性。临床医生在考虑混合装置配置时应谨慎行事,并确保对使用此类植入物的患者进行严格的随访。
{"title":"Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft","authors":"Giulio Accarino ,&nbsp;Aniello Enrico Puca ,&nbsp;Antonia Rinaldi ,&nbsp;Giovanni Fornino ,&nbsp;Giancarlo Accarino ,&nbsp;Davide Turchino ,&nbsp;Raffaele Serra ,&nbsp;Sergio Furgiuele ,&nbsp;Carmine Vecchione ,&nbsp;Umberto Marcello Bracale","doi":"10.1016/j.avsg.2024.10.024","DOIUrl":"10.1016/j.avsg.2024.10.024","url":null,"abstract":"<div><h3>Background</h3><div>The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff. This study aims to evaluate the long-term outcomes of patients treated with an all-Endologix implant versus a combination of Endologix and Medtronic devices.</div></div><div><h3>Methods</h3><div>This retrospective, single-center study included 134 consecutive AAA patients who underwent endovascular aneurysm repair (EVAR) using the AFX unibody endograft paired with suprarenal aortic cuffs from Endologix (<em>n</em> = 86) or Medtronic (<em>n</em> = 48) between November 2011 and November 2022. Patients were divided into 2 groups based on the type of aortic cuff used. The primary outcome was the occurrence of type 3A endoleaks at the longest available follow-up. Secondary outcomes included any endoleak, reintervention rates, all-cause mortality, and aneurysm-related death.</div></div><div><h3>Results</h3><div>The median follow-up was 41 months, and type 3A endoleaks occurred after a mean 34.8 months in 6 patients (4.5%), which is significantly more frequent in the mixed-device group (12.8%) (<em>P</em> &lt; 0.001). Type 3A endoleak occurred regardless of overlap and developed over time. Endoleaks of any type were reported in 17 patients. Reinterventions were needed in 12 patients. The use of an Endurant cuff was associated with a significantly increased risk of type 3A endoleaks (hazard ratio [HR] 16.5; 95% [CI] 1.9–143; <em>P</em> = 0.011) and reinterventions (HR 9.67; 95% CI 1.9–49.6; <em>P</em> = 0.006).</div></div><div><h3>Conclusions</h3><div>Combining endografts from different manufacturers, especially those with differing materials and sealing mechanisms, may compromise the long-term integrity of certain EVAR repairs. Clinicians should exercise caution when considering mixed-device configurations and ensure rigorous follow-up for patients with such implants.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 122-130"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142708940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery 经皮进入腋动脉进行血管内介入治疗的可行性和安全性。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.018
Caleb D. Alterman, Anton D. Perera, Prateek K. Gupta, Daniel M. Alterman

Background

Endovascular treatment of peripheral arterial disease requires safe and reliable arterial access. This study evaluates the feasibility and safety of percutaneous axillary artery access for endovascular therapy. A variety of anatomic and logistic obstacles can be overcome with upper extremity access. In this retrospective case review, we describe our experience with percutaneous trans-axillary access for lower extremity peripheral arterial disease intervention.

Methods

Medical records of all patients undergoing axillary artery percutaneous access from December 2021 to August 2024 were reviewed. Demographic data, procedural details, and complications such as pseudoaneurysm, hematoma, nerve injury, and closure device success were analyzed. Technical success and perioperative complications—including bruising, edema, hematoma, nerve injury, infection, thrombosis, and pseudoaneurysm—were assessed. Clinical outcomes were analyzed via follow-up clinic records.

Results

During the study period, 79 axillary artery accesses were performed on 64 patients. The patients were 55% male and had typical vascular comorbidities: hypertension (87%), hyperlipidemia (68%), coronary artery disease (27%), stroke (19%), and diabetes (16%); 58% were active tobacco users, and 80% were former tobacco users. Axillary access facilitated peripheral endovascular procedures, including iliac intervention (55), femoral (44), mesenteric (16), tibial (11), and embolization or visceral aneurysm treatments. A 6F sheath and ultrasound-guided Angio-Seal closure device were uniformly employed, with no major complications, perioperative deaths, or reoperations required. Minor complications of bruising and edema were present in 11 patients (14%). Other minor complications such as hematoma, nerve injury, thrombosis, dissection, pseudoaneurysm, or limb ischemia were absent.

Conclusions

Percutaneous axillary artery access demonstrates promise for complex endovascular interventions with a favorable safety profile. Advantages include avoidance of unfavorable femoral anatomy, improved working length compared with radial access, and enhanced control of visceral therapy. Bilateral iliac and lower extremity therapy is feasible in a single treatment as well. Percutaneous axillary artery access is a safe, reliable adjunct for enhancing endovascular arterial intervention capabilities.
目的:外周动脉疾病的血管内治疗需要安全可靠的动脉通路。本研究评估了经皮腋动脉入路进行血管内治疗的可行性和安全性。上肢入路可以克服各种解剖和后勤障碍。在这篇回顾性病例回顾中,我们介绍了经皮经腋动脉入路进行下肢外周动脉疾病介入治疗的经验:方法:回顾 2021 年 12 月至 2024 年 8 月期间所有接受腋动脉经皮入路手术患者的病历。分析了人口统计学数据、手术细节以及假性动脉瘤、血肿、神经损伤和闭合装置成功率等并发症。评估了技术成功率和围手术期并发症,包括瘀伤、水肿、血肿、神经损伤、感染、血栓形成和假性动脉瘤。临床结果通过随访门诊记录进行分析:研究期间,共为 64 名患者实施了 79 例腋窝动脉入路手术。患者中55%为男性,具有典型的血管并发症:高血压(87%)、高脂血症(68%)、冠心病(27%)、中风(19%)和糖尿病(16%);58%是活跃的烟草使用者,80%曾是烟草使用者。腋窝入路为外周血管内手术提供了便利,包括髂动脉介入(55例)、股动脉介入(44例)、肠系膜动脉介入(16例)、胫骨动脉介入(11例)以及栓塞或内脏动脉瘤治疗。所有手术都使用了6F鞘和超声引导下的Angio-Seal闭合装置,没有出现重大并发症、围手术期死亡或需要再次手术。11名患者(14%)出现了瘀伤和水肿等轻微并发症。其他轻微并发症如血肿、神经损伤、血栓形成、夹层、假性动脉瘤或肢体缺血等均未出现:结论:经皮腋动脉入路有望用于复杂的血管内介入治疗,安全性良好。其优点包括避免了不利的股动脉解剖结构,与桡动脉入路相比工作长度更长,并加强了对内脏治疗的控制。双侧髂动脉和下肢的治疗也可在一次治疗中完成。经皮腋动脉入路是增强血管内动脉介入能力的一种安全可靠的辅助手段。
{"title":"Feasibility and Safety of Endovascular Interventions via Percutaneous Access to the Axillary Artery","authors":"Caleb D. Alterman,&nbsp;Anton D. Perera,&nbsp;Prateek K. Gupta,&nbsp;Daniel M. Alterman","doi":"10.1016/j.avsg.2024.10.018","DOIUrl":"10.1016/j.avsg.2024.10.018","url":null,"abstract":"<div><h3>Background</h3><div>Endovascular treatment of peripheral arterial disease requires safe and reliable arterial access. This study evaluates the feasibility and safety of percutaneous axillary artery access for endovascular therapy. A variety of anatomic and logistic obstacles can be overcome with upper extremity access. In this retrospective case review, we describe our experience with percutaneous trans-axillary access for lower extremity peripheral arterial disease intervention.</div></div><div><h3>Methods</h3><div>Medical records of all patients undergoing axillary artery percutaneous access from December 2021 to August 2024 were reviewed. Demographic data, procedural details, and complications such as pseudoaneurysm, hematoma, nerve injury, and closure device success were analyzed. Technical success and perioperative complications—including bruising, edema, hematoma, nerve injury, infection, thrombosis, and pseudoaneurysm—were assessed. Clinical outcomes were analyzed via follow-up clinic records.</div></div><div><h3>Results</h3><div>During the study period, 79 axillary artery accesses were performed on 64 patients. The patients were 55% male and had typical vascular comorbidities: hypertension (87%), hyperlipidemia (68%), coronary artery disease (27%), stroke (19%), and diabetes (16%); 58% were active tobacco users, and 80% were former tobacco users. Axillary access facilitated peripheral endovascular procedures, including iliac intervention (55), femoral (44), mesenteric (16), tibial (11), and embolization or visceral aneurysm treatments. A 6F sheath and ultrasound-guided Angio-Seal closure device were uniformly employed, with no major complications, perioperative deaths, or reoperations required. Minor complications of bruising and edema were present in 11 patients (14%). Other minor complications such as hematoma, nerve injury, thrombosis, dissection, pseudoaneurysm, or limb ischemia were absent.</div></div><div><h3>Conclusions</h3><div>Percutaneous axillary artery access demonstrates promise for complex endovascular interventions with a favorable safety profile. Advantages include avoidance of unfavorable femoral anatomy, improved working length compared with radial access, and enhanced control of visceral therapy. Bilateral iliac and lower extremity therapy is feasible in a single treatment as well. Percutaneous axillary artery access is a safe, reliable adjunct for enhancing endovascular arterial intervention capabilities.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 194-202"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Thrombotic Syndrome Morbidity in Mechanical Thrombectomy Versus Pharmacomechanical Catheter-Directed Thrombolysis of Iliofemoral Deep Venous Thrombosis 髂股深静脉血栓的机械取栓术与药物机械导管定向溶栓术的血栓后综合征发病率。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.11.007
Jack K. Donohue , Kevin Li , Anthony Tang , Rachel J. Kann , Lena Vodovotz , Adham N. Abou Ali , Rabih A. Chaer , Natalie D. Sridharan

Background

Iliofemoral deep venous thrombosis is strongly associated with post-thrombotic syndrome (PTS). Interventional treatment options include catheter-directed thrombolysis and pharmacomechanical thrombectomy. More recently, there has been a wide dissemination of large-bore devices for mechanical thrombectomy (MT). Both treatment types have been shown to be effective in clinical practice; however, the rates of PTS after MT are poorly characterized.

Methods

We conducted a retrospective review of patients with acute iliofemoral deep venous thrombosis from 2007 to 2022. Patients were divided into 2 treatment groups: pharmacomechanical catheter-directed thrombolysis (PCDT) and MT with large-bore devices. Our primary endpoint was PTS (Villalta score >4). Secondary outcomes included vessel patency, mortality, and moderate/severe PTS (Villalta score >9). Predictors of PTS were analyzed using multivariable logistic regression.

Results

The median age of our cohort (n = 349) was 49 (interquartile range 35–63) years, 54.2% were female. There were 294 (84.2%) patients treated with PCDT. There were no significant baseline characteristic differences between patients treated with PCDT versus MT aside from increased preoperative anticoagulant use in the MT cohort. The overall rate of PTS was 19.1%. There were no differences in rates of PTS, moderate-severe PTS, stent patency, mortality between groups, or hospital length of stay. However, patients treated with MT had higher rates of single operating room visit during their admission treatment relative to patients that underwent PCDT (33.3% vs. 9.0%, P < 0.01) and decreased intensive care unit length of stay (2 (1–3) vs. 0.5 (0–2), P < 0.01). MT treatment was not a risk factor for the development of PTS (adjusted odds ratio [aOR] 0.73; [95% confidence interval {CI} 0.30, 1.74]; P = 0.47) or associated with increased Villalta score (β: −0.34; [95% CI–1.28, 0.60]; P = 0.47). Infrainguinal deep venous thrombosis extension (aOR 2.18; [95% CI 1.16, 4.09]; P = 0.02), prior deep venous thrombosis (aOR 2.67; [95% CI 1.38, 5.13]; P < 0.01), and a hypercoagulable state (aOR 2.32; [95% CI 1.19, 4.50]; P = 0.01) were associated with increased risk of PTS.

Conclusions

Treatment with large-bore MT was not a significant predictor for the development of PTS. MT appears safe, durable, and associated with greater rates of single operating room visit relative to PCDT, which suggests that rapid thrombus removal may be of value.
目的:髂股深静脉血栓(IFDVT)与血栓后综合征(PTS)密切相关。介入治疗方法包括导管引导溶栓(CDT)和药物机械血栓切除术(PMT)。最近,用于机械血栓切除术(MT)的大口径设备得到广泛推广。这两种治疗方法在临床实践中都被证明是有效的;然而,MT 治疗后的 PTS 发生率却鲜为人知:我们对 2007-2022 年间的急性 IFDVT 患者进行了回顾性研究。患者被分为两个治疗组:PCDT组和使用大口径设备的MT组。我们的主要终点是 PTS(Villalta 评分 > 4)。次要结局包括血管通畅、死亡率和中度/重度 PTS(Villalta 评分 > 9)。采用多变量逻辑回归分析了PTS的预测因素:队列(n = 349)的中位年龄为 49(IQR 35 - 63)岁,54.2% 为女性。294名患者(84.2%)接受了PCDT治疗。接受 PCDT 治疗的患者与接受 MT 治疗的患者之间没有明显的基线特征差异,只是 MT 组患者术前使用抗凝剂的情况有所增加。PTS总发生率为19.1%。两组患者的 PTS、中度-重度 PTS、支架通畅率、死亡率或住院时间(LOS)均无差异。然而,与接受 PCDT 的患者相比,接受 MT 治疗的患者在入院治疗期间的单次手术室就诊率更高(33.3% 对 9.0%,P < 0.01),重症监护室的住院时间更短(2 (1-3) 对 0.5 (0-2),P < 0.01)。MT 治疗不是 PTS 发生的风险因素(aOR 0.73;[95%CI 0.30,1.74];p = 0.47),也与 Villalta 评分增加无关(β:-0.34;[95%CI -1.28,0.60];p = 0.47)。腹股沟下 DVT 扩展(aOR 2.18;[95%CI 1.16,4.09];p = 0.02)、既往 DVT(aOR 2.67;[95%CI 1.38,5.13];p <0.01)和高凝状态(aOR 2.32;[95%CI 1.19,4.50];p = 0.01)与 PTS 风险增加相关:结论:使用大口径 MT 治疗并不能显著预测 PTS 的发生。与 PCDT 相比,MT 显得安全、持久,且单次手术室探视率更高,这表明快速清除血栓可能具有价值。
{"title":"Post-Thrombotic Syndrome Morbidity in Mechanical Thrombectomy Versus Pharmacomechanical Catheter-Directed Thrombolysis of Iliofemoral Deep Venous Thrombosis","authors":"Jack K. Donohue ,&nbsp;Kevin Li ,&nbsp;Anthony Tang ,&nbsp;Rachel J. Kann ,&nbsp;Lena Vodovotz ,&nbsp;Adham N. Abou Ali ,&nbsp;Rabih A. Chaer ,&nbsp;Natalie D. Sridharan","doi":"10.1016/j.avsg.2024.11.007","DOIUrl":"10.1016/j.avsg.2024.11.007","url":null,"abstract":"<div><h3>Background</h3><div>Iliofemoral deep venous thrombosis is strongly associated with post-thrombotic syndrome (PTS). Interventional treatment options include catheter-directed thrombolysis and pharmacomechanical thrombectomy. More recently, there has been a wide dissemination of large-bore devices for mechanical thrombectomy (MT). Both treatment types have been shown to be effective in clinical practice; however, the rates of PTS after MT are poorly characterized.</div></div><div><h3>Methods</h3><div>We conducted a retrospective review of patients with acute iliofemoral deep venous thrombosis from 2007 to 2022. Patients were divided into 2 treatment groups: pharmacomechanical catheter-directed thrombolysis (PCDT) and MT with large-bore devices. Our primary endpoint was PTS (Villalta score &gt;4). Secondary outcomes included vessel patency, mortality, and moderate/severe PTS (Villalta score &gt;9). Predictors of PTS were analyzed using multivariable logistic regression.</div></div><div><h3>Results</h3><div>The median age of our cohort (<em>n</em> = 349) was 49 (interquartile range 35–63) years, 54.2% were female. There were 294 (84.2%) patients treated with PCDT. There were no significant baseline characteristic differences between patients treated with PCDT versus MT aside from increased preoperative anticoagulant use in the MT cohort. The overall rate of PTS was 19.1%. There were no differences in rates of PTS, moderate-severe PTS, stent patency, mortality between groups, or hospital length of stay. However, patients treated with MT had higher rates of single operating room visit during their admission treatment relative to patients that underwent PCDT (33.3% vs. 9.0%, <em>P</em> &lt; 0.01) and decreased intensive care unit length of stay (2 (1–3) vs. 0.5 (0–2), <em>P</em> &lt; 0.01). MT treatment was not a risk factor for the development of PTS (adjusted odds ratio [aOR] 0.73; [95% confidence interval {CI} 0.30, 1.74]; <em>P</em> = 0.47) or associated with increased Villalta score (β: −0.34; [95% CI–1.28, 0.60]; <em>P</em> = 0.47). Infrainguinal deep venous thrombosis extension (aOR 2.18; [95% CI 1.16, 4.09]; <em>P</em> = 0.02), prior deep venous thrombosis (aOR 2.67; [95% CI 1.38, 5.13]; <em>P</em> &lt; 0.01), and a hypercoagulable state (aOR 2.32; [95% CI 1.19, 4.50]; <em>P</em> = 0.01) were associated with increased risk of PTS.</div></div><div><h3>Conclusions</h3><div>Treatment with large-bore MT was not a significant predictor for the development of PTS. MT appears safe, durable, and associated with greater rates of single operating room visit relative to PCDT, which suggests that rapid thrombus removal may be of value.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 55-62"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization 阻力指数是下肢远端动脉血管再通的预后因素。
IF 1.4 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-02-01 DOI: 10.1016/j.avsg.2024.10.019
Isadora Ísis Fernandes Vieira , Emmanuelle Tenório Albuquerque Godoi Berenguer de Barros E. Silva , Gabriela de Oliveira Buril , Carlos Henrique Nascimento Domingues da Silva , Esdras Marques Lins

Background

Critical limb ischemia (CLI) of the lower limbs (LLs) is a severe condition caused by peripheral arterial obstructive disease (PAOD). Surgical planning for CLI requires the study of limb circulation, and the vascular resistance index (RI) measured by Doppler ultrasound (US) has been used to aid in surgical decision-making. The objective is to correlate the RI of recipient arteries with the patency of LL revascularization surgeries in patients with CLI.

Methods

Prospective cohort study conducted from July 2021 to March 2023. The RI of the recipient arteries was evaluated preoperatively by US in 58 patients with CLI who underwent infrainguinal open or endovascular revascularizations, hospitalized in the Vascular Surgery Department of the Hospital das Clínicas of Empresa Brasileira de Serviços Hospitalares/Universidade Federal de Pernambuco. After 30 days of surgery, all patients were evaluated for the presence of pulses in the revascularized limb and the ankle brachial index (ABI) was measured in all cases. Statistical analysis was conducted with a 95% confidence level, and the Student's t-test was used to compare 2 independent samples.

Results

Clinical evaluation and ABI assessment of revascularization patency after 30 days revealed that infragenicular revascularizations that occluded had an average RI of 0.72 (SD ± 0.16), while patent revascularizations had a mean RI of 0.69 (SD ± 0.17) without statistical significance (P = 0.658).

Conclusions

Despite the lack of statistical significance, the study observed that a lower preoperative RI of the distal recipient artery was associated with greater patency of the revascularization surgery after 30 days.
背景:下肢严重缺血(CLI)是由外周动脉阻塞性疾病(PAOD)引起的一种严重疾病。CLI的手术计划需要对肢体循环进行研究,多普勒超声(US)测量的血管阻力指数(RI)已被用于辅助手术决策:将受体动脉RI与CLI患者LL血管再通手术的通畅性相关联:方法:2021年7月至2023年3月进行的前瞻性队列研究。58名慢性肢体缺血(CLI)患者在EBSERH/UFPE医院(HC-EBSERH/UFPE)血管外科住院,接受了腹股沟下开放或血管内血运重建手术,术前通过US对受体动脉的RI进行了评估。手术30天后,对所有患者的血管再通肢体是否有搏动进行评估,并对所有病例的踝肱指数(ABI)进行测量:结果:临床评估和 30 天后血管再通的 ABI 评估显示,闭塞的膝下血管再通平均 RI 为 0.72(sd ± 0.16),而通畅的血管再通平均 RI 为 0.69(sd ± 0.17),但无统计学意义(p = 0.658):尽管缺乏统计学意义,但该研究观察到远端受体动脉术前 RI 较低与 30 天后血管再通手术的通畅率较高有关。
{"title":"Resistance Index as a Prognostic Factor for Patency in Distal Lower Limb Arterial Revascularization","authors":"Isadora Ísis Fernandes Vieira ,&nbsp;Emmanuelle Tenório Albuquerque Godoi Berenguer de Barros E. Silva ,&nbsp;Gabriela de Oliveira Buril ,&nbsp;Carlos Henrique Nascimento Domingues da Silva ,&nbsp;Esdras Marques Lins","doi":"10.1016/j.avsg.2024.10.019","DOIUrl":"10.1016/j.avsg.2024.10.019","url":null,"abstract":"<div><h3>Background</h3><div>Critical limb ischemia (CLI) of the lower limbs (LLs) is a severe condition caused by peripheral arterial obstructive disease (PAOD). Surgical planning for CLI requires the study of limb circulation, and the vascular resistance index (RI) measured by Doppler ultrasound (US) has been used to aid in surgical decision-making. The objective is to correlate the RI of recipient arteries with the patency of LL revascularization surgeries in patients with CLI.</div></div><div><h3>Methods</h3><div>Prospective cohort study conducted from July 2021 to March 2023. The RI of the recipient arteries was evaluated preoperatively by US in 58 patients with CLI who underwent infrainguinal open or endovascular revascularizations, hospitalized in the Vascular Surgery Department of the Hospital das Clínicas of Empresa Brasileira de Serviços Hospitalares/Universidade Federal de Pernambuco. After 30 days of surgery, all patients were evaluated for the presence of pulses in the revascularized limb and the ankle brachial index (ABI) was measured in all cases. Statistical analysis was conducted with a 95% confidence level, and the Student's <em>t</em>-test was used to compare 2 independent samples.</div></div><div><h3>Results</h3><div>Clinical evaluation and ABI assessment of revascularization patency after 30 days revealed that infragenicular revascularizations that occluded had an average RI of 0.72 (SD ± 0.16), while patent revascularizations had a mean RI of 0.69 (SD ± 0.17) without statistical significance (<em>P</em> = 0.658).</div></div><div><h3>Conclusions</h3><div>Despite the lack of statistical significance, the study observed that a lower preoperative RI of the distal recipient artery was associated with greater patency of the revascularization surgery after 30 days.</div></div>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":"111 ","pages":"Pages 360-366"},"PeriodicalIF":1.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of vascular surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1